Cell Source, Inc. (CLCS)
0.90
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
Cell Source Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Celldex Therapeutics, Inc. | 0.0044 |
| Plus Therapeutics, Inc. | 0.0042 |
| Atossa Therapeutics, Inc. | 0.00 |
| Abeona Therapeutics, Inc. | 0.1408 |
| Kiora Pharmaceuticals, Inc. | 0.018 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.2865M |
| Total Liabilities (Quarterly) | 19.08M |
| Shareholders Equity (Quarterly) | -18.80M |